A polypill that includes aspirin, a statin and three blood pressure lowering drugs could lower the lifetime risk of heart disease by 21% in men and 15% in women, a study in Latin America found. The polypill "would be cost-effective and could also be cost-saving," study leader Leonelo Bautista said. The study was published in the journal Health Affairs.
Study: Polypill linked to lower risk of heart disease
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||